Blue Horseshoe Stocks: MRTX Recap & More

 Mirati Therapeutics, Inc. MRTX

After reporting positive cancer trial results on Friday, we talked about MRTX being poised for a big move and we weren’t incorrect.

The stock exploded out of the gate right from the outset, and traded in an impressive range from 9.15 to 12.40 early on in the day. That was good for a 35% intraday run- excellent for a $9+ stock. This is the third time in as many weeks we’ve called a stock that was approaching the ten dollar range and saw it gain more than a third in value in a single session.

Not only did MRTX trade up big on many times more thanits average volume, but it managed to maintain well over half of its daily advance, so we’ll be interested to continue monitoring its activity as we kick off a fresh trading week.


Iconic Brands, Inc. ICNB

We want to place ICNB on bottom-watch after taking a look at the recent history of the chart. This stock exhibits some really nice volatility and is coming down off of a significant spike.

When it finds support and rebounds, we could see a notable swing trade opportunity. The last such swing took the stock from the .003 range to .014.

The company recently announced its brand of Prosecco endorsed by former supermodel Christie Brinkley would be carried by Publix stores, so we’ll also be looking for further updates on that part of the story as well.


Pluristem Therapeutics, Inc. PSTI

We tagged PSTI for observation roughly a month ago, and have since seen a moderate move up on the chart, and will want to continue monitoring the situation.

The run the stock has made thus far is a marginal 27%, but things this morning have taken an interesting turn as the company announced the FDA granted fast track status to one of its treatments.


Extended Watchlist:
RAD, ADYN, NBRV, ARWR, PTIE, BIOA, MBOT, TRXC, COGT

Blue Horseshoe Stocks: Options, News Play & More

Insmed, Inc. INSM – Options Review

We originally submitted our idea for the INSM options chain on Tuesday morning, tagging the INSM 09/15 $27-30 Calls on the heels of the company’s release of promising Phase-3 topline study results for its rare lung disease treatment.

Yesterday morning we updated our readers after the stock had made a marginal move which allowed for notable gains in just one of the four contracts in our observed range. However, we doubled down with our interest in these plays, mentioning that it seemed likely for the stock to provide a better chance at more sweeping gains and that’s just what happened.

The following moves were made yesterday afternoon which facilitated solid potential profits for anyone who was following along with the action. Those highly impressive gains were as follows:

$27 Calls – Range: .95-3.00 – Max Gain: 215%
$28 Calls – Range:  .25-2.00 – Max Gain: 700%
$29 Calls – Range: .40-1.60 – Max Gain: 300%
$30 Calls – Range: .50-1.55 – Max Gain: 210%
______

Fresh Ideas:
GoPro, Inc. GPRO – Weekly $9.50 & $10 Calls

Trivago N.V. TRVG – 10/20 $15 & 17.50 Calls


NXT-id, Inc. NXTD

We’re seeing a sizable gap-up taking place in the premarket this morning on NXTD. The big boost in activity is stemming from a huge news announcement published today concerning a deal the company struck with Bank of America to get its ‘FitPay’ contact-less device payment solutions installed in more than 9,000 Bank of America ATMs. (>>View PR)

With a blockbuster announcement such as this, we’re definitely going to want to observe the action as we head into week’s end and beyond.


Extended Watchlist:
CLNT, MNKD, PTN, IRT, COGT, ADAP, NLNK